https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-05-09 / Int. J. Oncol. 2011 Aug;39(2):493-504
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-05-09 / Int. J. Oncol. 2011 Aug;39(2):493-5042011-05-09 00:00:002021-11-15 16:58:35Important role of interferon regulatory factor (IRF)-3 in the interferon response of mouse macrophages upon infection by Newcastle disease virus
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-04-06 / J. Virol. 2011 Jun;85(12):6015-23
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-04-06 / J. Virol. 2011 Jun;85(12):6015-232011-04-06 00:00:002019-02-15 09:21:40Oncolytic specificity of Newcastle disease virus is mediated by selectivity for apoptosis-resistant cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-04-06 / Arch. Virol. 2011 Aug;156(8):1335-44
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-04-06 / Arch. Virol. 2011 Aug;156(8):1335-442011-04-06 00:00:002011-04-06 00:00:00Caspase- and p38-MAPK-dependent induction of apoptosis in A549 lung cancer cells by Newcastle disease virus
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-03-17 / Int. J. Oncol. 2011 Jun;38(6):1719-29
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-03-17 / Int. J. Oncol. 2011 Jun;38(6):1719-292011-03-17 00:00:002021-11-15 16:59:03Targeting of IL-2 and GM-CSF immunocytokines to a tumor vaccine leads to increased anti-tumor activity
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-02-09 / Cancer Res. 2011 Apr;71(7):2497-506
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-02-09 / Cancer Res. 2011 Apr;71(7):2497-5062011-02-09 00:00:002019-02-15 08:51:29IL-15 and type I interferon are required for activation of tumoricidal NK cells by virus-infected dendritic cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-02-01 / Zhongguo Dang Dai Er Ke Za Zhi 2011 Feb;13(2):149-52
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-02-01 / Zhongguo Dang Dai Er Ke Za Zhi 2011 Feb;13(2):149-522011-02-01 00:00:002011-02-01 00:00:00[Roles of Newcastle disease virus in human acute monocytic leukemia in vitro and in vivo]
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-01-18 / Mol. Ther. 2011 Apr;19(4):797-804
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-01-18 / Mol. Ther. 2011 Apr;19(4):797-8042011-01-18 00:00:002011-01-18 00:00:00Oncolytic virus-initiated protective immunity against prostate cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-12-18 / Vaccine 2011 Feb;29(6):1185-93
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-12-18 / Vaccine 2011 Feb;29(6):1185-932010-12-18 00:00:002021-11-15 16:59:23Antitumor vaccination by Newcastle Disease Virus Hemagglutinin-Neuraminidase plasmid DNA application: changes in tumor microenvironment and activation of innate anti-tumor immunity
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-12-01 / Int. J. Oncol. 2010 Dec;37(6):1439-52
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-12-01 / Int. J. Oncol. 2010 Dec;37(6):1439-522010-12-01 00:00:002021-11-15 16:59:47Transcriptome analysis and cytokine profiling of naive T cells stimulated by a tumor vaccine via CD3 and CD25
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-11-04 / Head Neck 2011 Oct;33(10):1394-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-11-04 / Head Neck 2011 Oct;33(10):1394-92010-11-04 00:00:002019-02-15 09:21:37Therapeutic effects of a fusogenic newcastle disease virus in treating head and neck cancer
